These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27595992)

  • 21. Comparison of Haemophilus influenzae Seroprevalence in Serum Samples Collected from 0- to 5-Year-Old Japanese Children in 1980, 1995, 2010, and 2012.
    Arai S; Satoh H; Okuno H; Morino S; Oishi K; Tanaka-Taya K
    Jpn J Infect Dis; 2020 Jan; 73(1):51-54. PubMed ID: 31474695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.
    Borrow R; Andrews N; Findlow H; Waight P; Southern J; Crowley-Luke A; Stapley L; England A; Findlow J; Miller E
    Clin Vaccine Immunol; 2010 Jan; 17(1):154-9. PubMed ID: 19906895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against
    Muri L; Schubart A; Thorburn C; Zamurovic N; Holbro T; Kammüller M; Pluschke G; Ispasanie E
    Front Immunol; 2022; 13():1020580. PubMed ID: 36578495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.
    Hutter J; Pasetti MF; Sanogo D; Tapia MD; Sow SO; Levine MM
    Am J Trop Med Hyg; 2012 Jun; 86(6):1026-31. PubMed ID: 22665612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.
    McVernon J; Johnson PD; Pollard AJ; Slack MP; Moxon ER
    Arch Dis Child; 2003 May; 88(5):379-83. PubMed ID: 12716702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?
    Rodriguez RS; Mascarenas C; Conde-Glez CJ; Inostroza J; Villanueva S; Velázquez ME; Sánchez-Alemán MA; Echániz G
    Clin Vaccine Immunol; 2010 Oct; 17(10):1639-41. PubMed ID: 20719986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.
    Madhi SA; Kuwanda L; Saarinen L; Cutland C; Mothupi R; Käyhty H; Klugman KP
    Vaccine; 2005 Dec; 23(48-49):5517-25. PubMed ID: 16107294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.
    Nix EB; Hawdon N; Gravelle S; Biman B; Brigden M; Malik S; McCready W; Ferroni G; Ulanova M
    Clin Vaccine Immunol; 2012 May; 19(5):766-71. PubMed ID: 22398246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Merino JM; Moro M; Navarro ML; Espín J; Omeñaca F; García-Sicilia J; Moreno-Pérez D; Ruiz-Contreras J; Centeno F; Barrio F; Cabanillas L; Muro M; Esporrin C; De Torres MJ; Caubet M; Boutriau D; Miller JM; Mesaros N
    Pediatr Infect Dis J; 2012 Oct; 31(10):1074-7. PubMed ID: 22828645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
    Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
    J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
    Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
    Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.
    Goldblatt D; Vaz AR; Miller E
    J Infect Dis; 1998 Apr; 177(4):1112-5. PubMed ID: 9534995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b.
    Mariani M; Luzzi E; Proietti D; Mancianti S; Casini D; Costantino P; van Gageldonk P; Berbers G
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):667-74. PubMed ID: 9729534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines.
    Tejedor JC; Brzostek J; Konior R; Grunert D; Kolhe D; Baine Y; Van Der Wielen M
    Clin Vaccine Immunol; 2016 Jul; 23(7):555-63. PubMed ID: 27145999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
    Barbour ML; Booy R; Crook DW; Griffiths H; Chapel HM; Moxon ER; Mayon-White D
    Pediatr Infect Dis J; 1993 Jun; 12(6):478-84. PubMed ID: 8345980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine.
    Mawas F; Peyre M; Beignon AS; Frost L; Del Giudice G; Rappuoli R; Muller S; Sesardic D; Partidos CD
    J Infect Dis; 2004 Sep; 190(6):1177-82. PubMed ID: 15319869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilus influenzae type b vaccination: long-term protection.
    Nascimento-Carvalho CM; de Andrade AL
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S109-14. PubMed ID: 16826309
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants.
    Gaensbauer JT; Rakhola JT; Onyango-Makumbi C; Mubiru M; Westcott JE; Krebs NF; Asturias EJ; Fowler MG; McFarland E; Janoff EN
    Clin Vaccine Immunol; 2014 Dec; 21(12):1661-7. PubMed ID: 25298109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjugate vaccines for preventing Haemophilus influenzae type b infections.
    Swingler G; Fransman D; Hussey G
    Cochrane Database Syst Rev; 2003; (4):CD001729. PubMed ID: 14583937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.